Jose Baselga JOSE BASELGA, Vall d’Hebron Hospital, Barcelona RAD001, a drug targeted at the mTor pathway, has been combined with letrozole in a randomised phase II trial in breast cancer. … Continue reading New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer